Core Viewpoint - Investors in uniQure N.V. have the opportunity to lead a securities fraud lawsuit against the company due to alleged violations of the Securities Exchange Act of 1934, specifically related to misleading statements about FDA approval and BLA timelines [1] Group 1: Lawsuit Details - The Schall Law Firm is reminding investors of a class action lawsuit against uniQure N.V. for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [1] - The class period for the lawsuit is defined as between September 24, 2025, and October 31, 2025, during which investors are encouraged to contact the firm before April 13, 2026 [1] - The lawsuit claims that uniQure made false and misleading statements regarding its ability to secure full FDA approval for its Pivotal Study and misrepresented the likelihood of delaying its BLA timeline [1] Group 2: Investor Impact - Investors who purchased uniQure's securities during the class period reportedly suffered damages when the truth about the company's misleading statements was revealed [1] - The Schall Law Firm specializes in securities class action lawsuits and represents investors globally, indicating a focus on protecting shareholder rights [1]

Rosen Law Firm Urges BlackRock TCP Capital Corp. (NASDAQ: TCPC) Stockholders with Large Losses to Contact the Firm for Information About Their Rights-# Rosen Law Firm Urges BlackRock TCP Capital Corp. (NASDAQ: TCPC) Stockholders with Large Losses to Contact the Firm for Information About Their RightsShare---NEW YORK--([BUSINESS WIRE])--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of BlackRock TCP Capital Corp. (NASDAQ: TCPC) betwee ...

RARE Investors: Kessler Topaz Meltzer & Check, LLP Reminds Investors of April 6, 2026 Deadline in Securities Fraud Class Action Lawsuit Filed Against Ultragenyx Pharmaceutical Inc.Feb 10, 2026 2:16 PM Eastern Standard Time# RARE Investors: Kessler Topaz Meltzer & Check, LLP Reminds Investors of April 6, 2026 Deadline in Securities Fraud Class Action Lawsuit Filed Against Ultragenyx Pharmaceutical Inc.Share--- Did you buy RARE common stock between August 3, 2023, and December 26, 2025?Affected Ultragenyx Pha ...

Kyndryl Holdings, Inc. ("Kyndryl†or the "Company†) (NYSE: KD) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON KYNDRYL HOLDINGS, INC. (KD), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On February 9, 2026, Kyndryl...## Securities Fraud Investigation Into Kyndryl Holdings, Inc. (KD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leadin ...

[https://www.bfalaw.com/cases/kyndryl-holdings-class-action-lawsuit].Why is Kyndryl Being Investigated for Violations of the Federal Securities Laws?Kyndryl is a provider of enterprise technology services offering advisory, implementation, and managed service capabilities to customers in more than 60 countries. Kyndryl is the world's largest IT infrastructure services provider.BFA is investigating whether Kyndryl misrepresented its cash management practices, including the drivers of its adjusted free cash f ...

Core Viewpoint - Ademi LLP is investigating potential securities fraud claims against Stellantis N.V. due to possibly inaccurate statements regarding its business operations and future prospects [1] Group 1: Investigation Focus - The investigation centers on whether Stellantis has been experiencing "poor operational execution" in its strategy to boost sales of electric vehicles [1] - Concerns are raised about the quality control of Stellantis' manufacturing processes [1] Group 2: Legal Context - Ademi LLP specializes in securities fraud and shareholder litigation, indicating a focus on protecting shareholder interests [1] - The investigation is being conducted without any cost or obligation to participants [1]

Deadline Alert: Ramaco Resources, Inc. (METC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud LawsuitFeb 3, 2026 1:48 PM Eastern Standard Time# Deadline Alert: Ramaco Resources, Inc. (METC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud LawsuitShare---LOS ANGELES--([BUSINESS WIRE])- - [Glancy Prongay Wolke & Rotter LLP] reminds investors of the upcoming March 31, 2026 deadline to file a lead plaintif ...

Core Viewpoint - Robbins LLP has announced a class action lawsuit against Picard Medical, Inc. for alleged fraudulent stock promotion activities that misled investors [1] Group 1: Allegations Against Picard Medical, Inc. - The lawsuit claims that Picard Medical was involved in a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals [1] - It is alleged that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [1] - The company's public statements and risk disclosures reportedly omitted any mention of false rumors and artificial trading activity that influenced the stock price [1] Group 2: Stock Price Impact - On October 24, 2025, Picard Medical's stock price fell sharply by 70%, dropping to $3.99 per share [1] - Following the initial crash, the stock price has continued to decline, reaching approximately $2.00 per share [1] Group 3: Class Action Participation - Investors who purchased Picard Medical securities between September 2, 2025, and October 31, 2025, may be eligible to participate in the class action [1] - Shareholders wishing to serve as lead plaintiff must file their papers with the court by April 3, 2026 [1] - Participation in the case is not required to be eligible for recovery, allowing investors to remain absent class members if they choose [1]

Core Viewpoint - Kahn Swick & Foti, LLC is investigating the proposed sale of SkyWater Technology, Inc. to IonQ, focusing on the adequacy of the price and the process leading to the transaction [1] Group 1: Proposed Transaction Details - Under the terms of the proposed sale, shareholders of SkyWater will receive $15.00 in cash and $20.00 in shares of IonQ common stock for each share of SkyWater owned [1] - The investigation aims to determine if the consideration offered undervalues SkyWater Technology [1] Group 2: Legal Inquiry - Kahn Swick & Foti, LLC is seeking to assess the adequacy of the proposed transaction and the process that led to it [1] - Shareholders who believe the transaction undervalues the company are encouraged to discuss their legal rights with KSF [1]

Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the sale of Stellar Bancorp, Inc. to Prosperity Bancshares, Inc. for 0.3803 shares of Prosperity common stock and $11.36 in cash per share of Stellar common stock, focusing on whether the transaction is fair to Stellar shareholders [1]. Group 1: Investigation Details - The investigation aims to determine if Stellar Bancorp and its board violated federal securities laws or breached fiduciary duties by not securing the best possible consideration for shareholders [1]. - Key concerns include whether Prosperity is underpaying for Stellar and if all material information necessary for shareholders to assess the merger consideration has been disclosed [1]. Group 2: Legal Representation - Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures, and other relief related to the proposed transaction [1]. - The firm operates on a contingent fee basis, meaning shareholders would not incur out-of-pocket legal fees or expenses [1].